Navigation Links
Uroplasty To Participate In The Oppenheimer 23rd Annual Healthcare Conference
Date:12/5/2012

MINNEAPOLIS, Dec. 5, 2012 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI), a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, today announced its participation in the Oppenheimer 23rd Annual Healthcare Conference on Thursday, December 13, 2012, at 1:00 p.m. ET at the Waldorf Hotel in New York. Medi Jiwani, Chief Financial Officer, will present and meet with investors one on one at the conference in New York City.

Attendance at the conference is by invitation only.  A live audio webcast of the presentation will be broadcast via the Internet. Those interested in listening to the webcast may access it at http://www.veracast.com/webcasts/opco/healthcare2012/29210507.cfm, or through Uroplasty's website at www.uroplasty.com. An archived replay of the presentation will be available for 90 days.

About Uroplasty, Inc.

Uroplasty, Inc., headquartered in Minnetonka, Minnesota, with wholly-owned subsidiaries in The Netherlands and the United Kingdom is a global medical company committed to offering transformative treatment options to specialty physicians. Our products are designed to help providers change the lives of their voiding dysfunction patients and strengthen the efficiency of their practices. Our focus is the continued commercialization of our Urgent® PC Neuromodulation System, the only FDA-cleared system that delivers percutaneous tibial nerve stimulation (PTNS) for the office-based treatment of overactive bladder and associated symptoms of urgency, frequency and urge incontinence. We also offer Macroplastique®, an injectable urethral bulking agent for the treatment of adult female stress urinary incontinence primarily due to intrinsic sphincter deficiency. For more information on the company and its products, please visit Uroplasty, Inc. at www.uroplasty.com.

For Further Information:

Uroplasty, Inc.

David Kaysen, President and CEO, or

Medi Jiwani, Vice President, CFO, Treasurer

952.426.6140

 

EVC Group

Doug Sherk/Jenifer Kirtland (Investors),
415.568.9349

Chris Gale (Media), 646.201.5431


'/>"/>
SOURCE Uroplasty, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Uroplasty To Participate In Two Upcoming Investor Conferences
2. Uroplasty Reports Fiscal Second Quarter 2013 Financial Results
3. Uroplasty To Participate In Two Upcoming Conferences
4. Uroplasty Reports Fiscal First Quarter 2013 Financial Results
5. Uroplasty to Issue First Quarter of Fiscal 2013 Financial Results on July 26, 2012
6. Uroplasty To Present At The JMP Securities Healthcare Conference
7. Uroplasty Reports Fiscal Fourth Quarter And Full Year 2012 Financial Results
8. Uroplasty Announces Product Development and New Clinical Trial Initiatives
9. Uroplasty to Present at the 11th Annual JMP Securities Research Conference
10. Rochester Medical Corporation to Participate in The Benchmark Company, LLC Micro Cap Discovery Conference
11. Rochester Medical Corporation to Participate in the 24th Annual Piper Jaffray Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... Digital Health Dialog, LLC dba EngagedMedia ... US Patent and Trademark Office of U.S. Patent ... for electronic opt-­in and processing of discount coupons ... compliance and otherwise. Logo - http://photos.prnewswire.com/prnh/20160524/371583LOGO ... "Our technology allows for individuals to opt­-in to ...
(Date:5/25/2016)... PUNE, India , May 25, 2016 /PRNewswire/ ... Pipeline Review, H1 2016"market research report that provides ... complete with comparative analysis at various stages, therapeutics ... route of administration (RoA) and molecule type, along ... releases. It also reviews key players involved in ...
(Date:5/24/2016)... , May 24, 2016 ... beide primären Endpunkte und demonstriert ... in ‚ausgezeichneter plus guter , ...    ,      (Logo: http://photos.prnewswire.com/prnh/20130829/633895-a ... heute neue positive Daten von der MORA-Studie der ...
Breaking Medicine Technology:
(Date:5/27/2016)... ... ... With over 60 percent of acute stroke survivors being left unable to ... in the rehabilitation process has steadily increased. Ekso Bionics had been working to help ... stroke. , Ekso Bionics has now received clearance from the U.S. Food and Drug ...
(Date:5/27/2016)... York, NY (PRWEB) , ... May 27, 2016 ... ... to casual readers, this installment is bolstered by inspiring human-interest stories, courtesy of ... and tech within the industry, from leading advocates, associations and industry leaders such ...
(Date:5/27/2016)... ... 2016 , ... Beleza Medspa has initiated a new program to ... the first time that Coolsculpting is being used for for more than just cosmetic ... they meet the prescribed body-fat standard, measured by the circumference-based tape method. The ...
(Date:5/27/2016)... ... May 27, 2016 , ... Aimed at nurses and ... stories, which come courtesy of leaders in the nursing and health care industry. It ... advocates and associations—namely Abilene Christian University. , As the nursing industry is coming ...
(Date:5/27/2016)... ... , ... With a team of certified experts, Validation Center ... its GMP accreditation, Validation Center is also a registered authority of the international ... , Validation Center is ISO17025 accredited and only offers its clients the latest ...
Breaking Medicine News(10 mins):